Abstract:LI-F type peptides (AMP-jsa9) produced by Paenibacillus polymyxa JSa-9 are a group of cyclic lipodepsipeptide antibiotics that exhibit a broad antimicrobial spectrum against Gram-positive bacteria and filamentous fungi, especially Bacillus cereus and Fusarium moniliforme. In this study, to better understand the antibacterial mechanism of AMP-jsa9 against B. cereus, the ultrastructure of AMP-jsa9-treated B. cereus cells was observed by both atomic force microscopy and transmission electron microscopy, and quantitative proteomic analysis was performed on proteins extracted from treated and untreated bacterial cells by using isobaric tag for relative and absolute quantitation (iTRAQ) labeling and LC-MS/MS analysis to access differentially expressed proteins. Furthermore, multiple experiments were conducted to validate the results of the proteomic analysis, including determinations of ATP, NAD(+)H, NADP(+)H, reactive oxygen species (ROS), the activities of catalase (CAT) and superoxide dismutase (SOD), and the relative expression of target genes by quantitative real-time PCR. Bacterial cells exposed to AMP-jsa9 showed irregular surfaces with bleb projections and concaves; we hypothesize that AMP-jsa9 penetrated the cell wall and was anchored on the cytoplasmic membrane and that ROS accumulated in the cell membrane after treatment with AMP-jsa9, modulating the bacterial membrane properties and increasing membrane permeability. Consequently, the blebs were formed on the cell wall by the impulsive force of the leakage of intercellular contents. iTRAQ-based proteomic analysis detected a total of 1317 proteins, including 176 differentially expressed proteins (75 upregulated (fold >2) and 101 downregulated (fold <0.5)). Based on proteome analysis, the putative pathways of AMP-jsa9 action against B. cereus can be summarized as: (i) inhibition of bacterial sporulation, thiamine biosynthesis, energy metabolism, DNA transcription and translation, and cell wall biosynthesis, through direct regulation of protein levels; and (ii) indirect effects on the same pathways through the accumulation of ROS and the consequent impairment of cellular functions, resulting from downregulation of antioxidant proteins, especially CAT and SOD. Biological significance: The mode of action of LI-F type antimicrobial peptides (AMP-jsa9) against B. cereus was elucidated at the proteomic level. Two pathways of AMP-jsa9 action upon B. cereus cells were identified and the mechanism of bleb formation on the surfaces of bacterial cells was predicted based on the results of ultrastructural observation and proteomic analysis. These results are helpful in understanding the mechanism of LI-F type peptides and in providing the theoretical base for applying AMP-jsa9 or its analogs to combat Gram-positive pathogenic bacteria in the food and feed industries.

[Breeding of High-Producing LI-F Lipopeptide Paenibacillus Polymyxa by Protoplast Fusion and Differential Expression Analysis of Fusion Strains].

Comparative Study on the Properties of Lipopeptide Products and Expression of Biosynthetic Genes from Bacillus Amyloliquefaciens XZ-173 in Liquid Fermentation and Solid-State Fermentation

Improved the lipopeptide production of Bacillus amyloliquefaciens HM618 under co-culture with the recombinant Corynebacterium glutamicum producing high-level proline

[Eukaryotic Expression of Leptospira Interrogans Lipl32/1-Ompl1/1 Fusion Gene Encoding Genus-Specific Protein Antigens and the Immunoreactivity of Expression Products].

Enhanced ε‐poly‐l‐lysine production in Streptomyces species by combining interspecific hybridization with multiple antibiotic resistance

Isolation and characterization of peptide antibiotics LI-F04 and polymyxin B6 produced by Paenibacillus polymyxa strain JSa-9

Design, characterization and expression of a novel hybrid peptides melittin (1–13)-LL37 (17–30)

High-level Production of a Candidacidal Peptide Lactoferrampin in Escherichia Coli by Fusion Expression.

Expression of the hybrid antimicrobial peptide lactoferrin–lysozyme in Pichia pastoris

Improved ε-Poly-lysine Production by Intergeneric Hybridization between Streptomyces griseofuscus and Brebvibacterium flavum

[High-Level Expression and Antimicrobial Activity of Recombinant N-terminal Porcine Lactoferrin].

Expression, Purification, and Characterization of a Novel Hybrid Peptide with Potent Antibacterial Activity.

Construction of Lipopeptide Mono-Producing Bacillus Strains and Comparison of Their Antimicrobial Activity

An Integrated Pipeline and Overexpression of a Novel Efflux Transporter, YoeA, Significantly Increases Plipastatin Production in Bacillus subtilis

Multimerization and fusion expression of bovine lactoferricin derivative LfcinB15-W4,10 in Escherichia coli

iTRAQ-based proteomic analysis of LI-F type peptides produced by Paenibacillus polymyxa JSa-9 mode of action against Bacillus cereus

Effect of translocation of NRPS thioesterase domain of Bacillomycin D synthase system on the synthesis of lipopeptides

Design and high-level expression of a hybrid antimicrobial peptide LF15-CA8 in Escherichia coli

CodY, ComA, DegU and Spo0A Controlling Lipopeptides Biosynthesis in Bacillus Amyloliquefaciens Fmbj.

Design and Heterologous Expression of a Novel Dimeric LL37 Variant in Pichia Pastoris.

Expression, Purification, and Antibacterial Activity of Bovine Lactoferrampin–Lactoferricin in Pichia pastoris